# Treatment for Bile Duct Cancer in the Liver

> **NCT02167711** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 24 (actual)

## Conditions studied

- Cholangio Carcinoma

## Interventions

- **DRUG:** SIRT Yttrium-90

## Key facts

- **NCT ID:** NCT02167711
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-17
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-02-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02167711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02167711, "Treatment for Bile Duct Cancer in the Liver". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT02167711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*